☆ 4.3 Letter

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

LEUKEMIA & LYMPHOMA (2018)

Get Full Text
Add to Collection

Journal

LEUKEMIA & LYMPHOMA
Volume 59, Issue 8, Pages 1981-1985

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2017.1403020

Keywords

-

Categories

Oncology Hematology

Funding

  1. Olink Bioscience, Uppsala, Sweden
  2. NIH/NCI Cancer Center [P30 CA008748]
  3. NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.